Shatha Ata Abdulgader
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shatha Ata Abdulgader has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abdulhadi M. Abdulwahed
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia
4 shared publications - Fahad Nasser Almajhdi
Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia
4 shared publications - Ibrahim M. Aziz
Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
4 shared publications - Mohamed Farrag
Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
4 shared publications - Reem Mohammed Alwhaibi
Department of Rehabilitation Sciences, College of Health and Rehabilitation Sciences, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia
4 shared publications - Abdulaziz M. Almuqrin
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia
3 shared publications
Latest Publications
- Open Access
Genomic Characterization and Phylogenetic Analysis of HA and NA Genes of Influenza B Virus in Riyadh (2024–2025): Implications for Vaccine Strain Match
Background: Influenza B virus (IBV) undergoes continuous genetic mutations that can affect vaccine effectiveness and immune evasion. Although considerable research on IBV epidemiology exists globally, understanding of its genetic behavior in Saudi Arabia remains limited. This study characterized the molecular epidemiology of IBV in Riyadh, Saudi Arabia, during the 2024–2025 influenza season and evaluated compatibility with the current vaccine strain. Methods: Nasopharyngeal samples (n = 363) were collected from individuals presenting with influenza-like illness at King Khalid University Hospital in Riyadh. Detection and subtyping of IBV were performed using RT-PCR. Complete sequencing of the hemagglutinin (HA) and neuraminidase (NA) genes was conducted on confirmed IBV isolates (n = 7), followed by phylogenetic analysis, amino acid substitution mapping, and glycosylation site prediction. Results: Of the 363 samples analyzed, 68 (18.7%) tested positive for IBV, with the majority occurring in adult females aged 15–64 years. Phylogenetic analysis revealed that all seven IBV isolates belonged to the Victoria lineage under subclade V1A.3a.2, corresponding to the current vaccine strain and strains from the 2022–2023 epidemic season. However, molecular analysis identified two substitutions (D129N and D197E) located in antigenic loop-150 and 190-helix, respectively, in the HA polypeptide that distinguished our strains from vaccine strain B/Austria/1359417/2021. Importantly, the N-glycosylation site at position 169 (NKT), which was present in B/Riyadh/1/2010, has been lost in the IBV strains circulating during 2020–2025. Conclusions: While phylogenetic clade compatibility indicates potential vaccine efficacy, the identified amino acid variations and loss of the glycosylation site underscore the necessity for ongoing molecular surveillance to monitor antigenic changes and evaluate vaccine effectiveness within the Saudi Arabian population.
Open AccessGenomic Characterization and Phylogenetic Analysis of HA and NA Genes of Influenza B Virus in Riyadh (2024–2025): Implications for Vaccine Strain Match
Background: Influenza B virus (IBV) undergoes continuous genetic mutations that can affect vaccine effectiveness and immune evasion. Although considerable research on IBV epidemiology exists globally, understanding of its genetic behavior in Saudi Arabia remains limited. This study characterized the molecular epidemiology of IBV in Riyadh, Saudi Arabia, during the 2024–2025 influenza season and evaluated compatibility with the current vaccine strain. Methods: Nasopharyngeal samples (n = 363) were collected from individuals presenting with influenza-like illness at King Khalid University Hospital in Riyadh. Detection and subtyping of IBV were performed using RT-PCR. Complete sequencing of the hemagglutinin (HA) and neuraminidase (NA) genes was conducted on confirmed IBV isolates (n = 7), followed by phylogenetic analysis, amino acid substitution mapping, and glycosylation site prediction. Results: Of the 363 samples analyzed, 68 (18.7%) tested positive for IBV, with the majority occurring in adult females aged 15–64 years. Phylogenetic analysis revealed that all seven IBV isolates belonged to the Victoria lineage under subclade V1A.3a.2, corresponding to the current vaccine strain and strains from the 2022–2023 epidemic season. However, molecular analysis identified two substitutions (D129N and D197E) located in antigenic loop-150 and 190-helix, respectively, in the HA polypeptide that distinguished our strains from vaccine strain B/Austria/1359417/2021. Importantly, the N-glycosylation site at position 169 (NKT), which was present in B/Riyadh/1/2010, has been lost in the IBV strains circulating during 2020–2025. Conclusions: While phylogenetic clade compatibility indicates potential vaccine efficacy, the identified amino acid variations and loss of the glycosylation site underscore the necessity for ongoing molecular surveillance to monitor antigenic changes and evaluate vaccine effectiveness within the Saudi Arabian population.
- Open Access
- 19 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Genetic characterization of influenza A (A/H3N2) viruses reveals antigenic drift in receptor binding domain and possible vaccine mismatch in strains circulating in Riyadh, Saudi Arabia, 2024–2025
Introduction: Influenza A/H3N2 viruses undergo continuous antigenic evolution, necessitating ongoing surveillance for informed vaccine strain selection. This study characterized the molecular epidemiology of A/H3N2 viruses circulating in Riyadh, Saudi Arabia, during the winter season of 2024-2025 and assessed their compatibility with current vaccine strains. Methods: Nasopharyngeal samples (NPAs) (n=363) were collected from patients presenting with influenza-like illness at King Khalid University Hospital in Riyadh. Influenza A/H3N2 detection and subtyping were performed using RT-PCR. Complete hemagglutinin (HA) and neuraminidase (NA) genes sequencing was conducted on confirmed A/H3N2 strains (n=7), followed by phylogenetic analysis, amino acid substitution mapping, and glycosylation site prediction. Results: Of 363 samples tested, 110 (30.3%) were positive for influenza A, with 42 (38.2%) identified as A/H3N2 and 68 (61.8%) as A/H1N1pdm09. Phylogenetic analysis revealed that all seven sequenced A/H3N2 strains belonged to clade 2a.3a.1, which is identical to the current vaccine strain clade. However, molecular analysis identified four amino acid substitutions in the HA glycoprotein that distinguished circulating strains from the A/H3N2 vaccine strain A/Croatia/10136RV/2023. The NA gene was homologous to the study isolates, indicating a possible match with the vaccine. Notably, all study strains showed the same N-glycosylation sites that are present in the vaccine strain. Conclusions: While phylogenetic clade compatibility suggests potential vaccine effectiveness, the observed amino acid differences highlight the importance of continued molecular surveillance to monitor antigenic drift and assess vaccine performance in the Saudi Arabian population.
- 19 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessGenetic characterization of influenza A (A/H3N2) viruses reveals antigenic drift in receptor binding domain and possible vaccine mismatch in strains circulating in Riyadh, Saudi Arabia, 2024–2025
Introduction: Influenza A/H3N2 viruses undergo continuous antigenic evolution, necessitating ongoing surveillance for informed vaccine strain selection. This study characterized the molecular epidemiology of A/H3N2 viruses circulating in Riyadh, Saudi Arabia, during the winter season of 2024-2025 and assessed their compatibility with current vaccine strains. Methods: Nasopharyngeal samples (NPAs) (n=363) were collected from patients presenting with influenza-like illness at King Khalid University Hospital in Riyadh. Influenza A/H3N2 detection and subtyping were performed using RT-PCR. Complete hemagglutinin (HA) and neuraminidase (NA) genes sequencing was conducted on confirmed A/H3N2 strains (n=7), followed by phylogenetic analysis, amino acid substitution mapping, and glycosylation site prediction. Results: Of 363 samples tested, 110 (30.3%) were positive for influenza A, with 42 (38.2%) identified as A/H3N2 and 68 (61.8%) as A/H1N1pdm09. Phylogenetic analysis revealed that all seven sequenced A/H3N2 strains belonged to clade 2a.3a.1, which is identical to the current vaccine strain clade. However, molecular analysis identified four amino acid substitutions in the HA glycoprotein that distinguished circulating strains from the A/H3N2 vaccine strain A/Croatia/10136RV/2023. The NA gene was homologous to the study isolates, indicating a possible match with the vaccine. Notably, all study strains showed the same N-glycosylation sites that are present in the vaccine strain. Conclusions: While phylogenetic clade compatibility suggests potential vaccine effectiveness, the observed amino acid differences highlight the importance of continued molecular surveillance to monitor antigenic drift and assess vaccine performance in the Saudi Arabian population.
- Open Access
- 30 December 2025
- Published by Springer Nature in Research Square
Genetic Characterization of Influenza A (A/H3N2) Viruses Reveals Antigenic Drift in Receptor Binding Domain and Possible Vaccine Mismatch in Strains Circulating in Riyadh, Saudi Arabia, 2024-2025
Introduction: Influenza A/H3N2 viruses undergo continuous antigenic evolution, necessitating ongoing surveillance for informed vaccine strain selection. This study characterized the molecular epidemiology of H3N2 viruses circulating in Riyadh, Saudi Arabia, during the winter season of 2024-2025 and assessed their compatibility with current vaccine strains. Methods: Nasopharyngeal samples (NPAs) (n=363) were collected from patients presenting with influenza-like illness at King Khalid University Hospital in Riyadh. Influenza A/H3N2 detection and subtyping were performed using RT-PCR. Complete hemagglutinin (HA) and neuraminidase (NA) gene sequencing was conducted on confirmed A/H3N2 strains (n=7), followed by phylogenetic analysis, amino acid substitution mapping, and glycosylation site prediction. Results: Of 363 samples tested, 110 (30.3%) were positive for influenza A, with 42 (38.2%) identified as A/H3N2 and 68 (61.8%) as A/H1N1pdm09. Phylogenetic analysis revealed that all seven sequenced A/H3N2 strains belonged to clade 2a.3a.1, which is identical to the current vaccine strain clade. However, molecular analysis identified six amino acid substitutions in the HA gene and four in the NA gene that distinguished circulating strains from the A/H3N2 vaccine strain A/Thailand/8/2022. Notably, all study strains showed deletion of an N-glycosylation site (N122S) that is present in the vaccine strain. Conclusions: While phylogenetic clade compatibility suggests potential vaccine effectiveness, the observed amino acid differences and glycosylation site deletion highlight the importance of continued molecular surveillance to monitor antigenic drift and assess vaccine performance in the Saudi Arabian population.
- 30 December 2025
- Published by Springer Nature in Research Square
Open AccessGenetic Characterization of Influenza A (A/H3N2) Viruses Reveals Antigenic Drift in Receptor Binding Domain and Possible Vaccine Mismatch in Strains Circulating in Riyadh, Saudi Arabia, 2024-2025
Introduction: Influenza A/H3N2 viruses undergo continuous antigenic evolution, necessitating ongoing surveillance for informed vaccine strain selection. This study characterized the molecular epidemiology of H3N2 viruses circulating in Riyadh, Saudi Arabia, during the winter season of 2024-2025 and assessed their compatibility with current vaccine strains. Methods: Nasopharyngeal samples (NPAs) (n=363) were collected from patients presenting with influenza-like illness at King Khalid University Hospital in Riyadh. Influenza A/H3N2 detection and subtyping were performed using RT-PCR. Complete hemagglutinin (HA) and neuraminidase (NA) gene sequencing was conducted on confirmed A/H3N2 strains (n=7), followed by phylogenetic analysis, amino acid substitution mapping, and glycosylation site prediction. Results: Of 363 samples tested, 110 (30.3%) were positive for influenza A, with 42 (38.2%) identified as A/H3N2 and 68 (61.8%) as A/H1N1pdm09. Phylogenetic analysis revealed that all seven sequenced A/H3N2 strains belonged to clade 2a.3a.1, which is identical to the current vaccine strain clade. However, molecular analysis identified six amino acid substitutions in the HA gene and four in the NA gene that distinguished circulating strains from the A/H3N2 vaccine strain A/Thailand/8/2022. Notably, all study strains showed deletion of an N-glycosylation site (N122S) that is present in the vaccine strain. Conclusions: While phylogenetic clade compatibility suggests potential vaccine effectiveness, the observed amino acid differences and glycosylation site deletion highlight the importance of continued molecular surveillance to monitor antigenic drift and assess vaccine performance in the Saudi Arabian population.
- Open Access
Genetic Divergence of H1N1pdm09 in Saudi Arabia: Unveiling a Novel N-Glycosylation Site and Its Role in Vaccine Mismatch
Background/Objectives: Influenza A virus undergoes continuous antigenic drift, necessitating annual vaccine reformulation. Saudi Arabia faces unique epidemiological challenges owing to mass gatherings during religious pilgrimages and the dynamic movement of foreign workers. This study aimed to characterize the genetic diversity of hemagglutinin (HA) and neuraminidase (NA) genes of influenza A viruses circulating in Riyadh and to assess their match with vaccine strains during the 2024–2025 period. Methods: Nasopharyngeal samples (n = 363) were collected from patients presenting with influenza-like illness. RT-PCR was used for detection and subtyping. Sequence and phylogenetic analysis of the complete HA and NA gene sequences from A/H1N1pdm09 strains (n = 7) were then performed. Results: Of the 363 samples, 110 (30.3%) were positive for influenza A; among these, 68 (61.8%) were A/H1N1pdm09, and 42 (38.2%) were H3N2. Phylogenetic analysis revealed that all A/H1N1pdm09 strains belonged to clade 5a.1, distinct from vaccine strains. In comparison with the vaccine strain A/Wisconsin/67/2022, seven amino acid substitutions in the HA gene and eight in the NA gene were recorded in Saudi circulating strains. The significant genetic divergence between circulating A/H1N1pdm09 strains and current vaccine strains indicates potential vaccine mismatch. Conclusions: The significant genetic divergence between circulating A/H1N1pdm09 strains and current vaccine strains suggests potential vaccine mismatch. Continuous surveillance programs along with vaccination plans are necessary to tackle the changing influenza A virus strains in the special epidemiological context of Saudi Arabia.
Open AccessGenetic Divergence of H1N1pdm09 in Saudi Arabia: Unveiling a Novel N-Glycosylation Site and Its Role in Vaccine Mismatch
Background/Objectives: Influenza A virus undergoes continuous antigenic drift, necessitating annual vaccine reformulation. Saudi Arabia faces unique epidemiological challenges owing to mass gatherings during religious pilgrimages and the dynamic movement of foreign workers. This study aimed to characterize the genetic diversity of hemagglutinin (HA) and neuraminidase (NA) genes of influenza A viruses circulating in Riyadh and to assess their match with vaccine strains during the 2024–2025 period. Methods: Nasopharyngeal samples (n = 363) were collected from patients presenting with influenza-like illness. RT-PCR was used for detection and subtyping. Sequence and phylogenetic analysis of the complete HA and NA gene sequences from A/H1N1pdm09 strains (n = 7) were then performed. Results: Of the 363 samples, 110 (30.3%) were positive for influenza A; among these, 68 (61.8%) were A/H1N1pdm09, and 42 (38.2%) were H3N2. Phylogenetic analysis revealed that all A/H1N1pdm09 strains belonged to clade 5a.1, distinct from vaccine strains. In comparison with the vaccine strain A/Wisconsin/67/2022, seven amino acid substitutions in the HA gene and eight in the NA gene were recorded in Saudi circulating strains. The significant genetic divergence between circulating A/H1N1pdm09 strains and current vaccine strains indicates potential vaccine mismatch. Conclusions: The significant genetic divergence between circulating A/H1N1pdm09 strains and current vaccine strains suggests potential vaccine mismatch. Continuous surveillance programs along with vaccination plans are necessary to tackle the changing influenza A virus strains in the special epidemiological context of Saudi Arabia.